Nuclear Medicine and Biology
Volume 35, Issue 6 , Pages 679-687 , August 2008

Radiolabeling of annexin A5 with 99mTc: comparison of HYNIC-Tc vs. iminothiolane-Tc-tricarbonyl conjugates

  • Marie-Laure Biechlin

      Affiliations

    • Faculté de Médecine Lyon-Sud (EA 3738), 69921 Oullins, France
    • Radiopharmacie, Centre Hospitalier de Chambéry, 73000 Chambéry, France
    • Corresponding Author InformationCorresponding authors. Marie-Laure Biechlin is to be contacted at Centre Hospitalier de Chambéry, Service de médecine nucléaire, Rue Pierre et Marie Curie, 73 000 Chambéry, France. Tel.: +33 4 79 96 50 72; fax: +33 4 79 96 51 78. Amaury du Moulinet d'Hardemare, Département de Chimie Moléculaire, Equipe de Chimie Inorganique Redox et Biomimétique, Université Joseph Fourier-Grenoble I (DCM UMR 5250, ICMG), 301 rue de la Chimie, 38041 Grenoble cedex 9, France. Tel.: +33 4 76 63 57 05; fax: +33 4 76 51 48 36.
    • ,
  • Alain Bonmartin

      Affiliations

    • Faculté de Médecine Lyon-Sud (EA 3738), 69921 Oullins, France
    • ,
  • François-Noël Gilly

      Affiliations

    • Faculté de Médecine Lyon-Sud (EA 3738), 69921 Oullins, France
    • ,
  • Marc Fraysse

      Affiliations

    • Radiopharmacie, Centre Hospitalier Lyon Sud, 69495 Pierre-Bénite, France
    • ,
  • Amaury du Moulinet d'Hardemare

      Affiliations

    • Département de Chimie Moléculaire, Equipe de Chimie Inorganique Redox et Biomimétique, Université Joseph Fourier-Grenoble I (DCM UMR 5250, ICMG), 38041 Grenoble cedex 9, France
    • Corresponding Author InformationCorresponding authors. Marie-Laure Biechlin is to be contacted at Centre Hospitalier de Chambéry, Service de médecine nucléaire, Rue Pierre et Marie Curie, 73 000 Chambéry, France. Tel.: +33 4 79 96 50 72; fax: +33 4 79 96 51 78. Amaury du Moulinet d'Hardemare, Département de Chimie Moléculaire, Equipe de Chimie Inorganique Redox et Biomimétique, Université Joseph Fourier-Grenoble I (DCM UMR 5250, ICMG), 301 rue de la Chimie, 38041 Grenoble cedex 9, France. Tel.: +33 4 76 63 57 05; fax: +33 4 76 51 48 36.

Received 18 March 2008 ,Revised 24 April 2008 ,Accepted 27 May 2008.

References 

  1. Moss S, Morgan R. The annexins. Genome Biol. 2004;5:219
  2. Boersma H, Kietselaer B, Stolk L, Bennaghmouch A, Hofstra L, Narula J, et al. Past, present and future of annexin V: from protein discovery to clinical applications. J Nucl Med. 2005;46:2035–2050
  3. Rongen G, Oyen W, Ramakers B, Riksen N, Boerman O, Steinmetz N, et al. Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation. 2005;111:173–178
  4. Rottey S, Slegers G, Van Belle S, Goethals I, Van de Wiele C. Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. J Nucl Med. 2006;47:1813–1818
  5. Karatchova M, Valdes O, Haas R, Hoebers F, Van den Brekel M, Van Zandwijk N, et al. Mapping of treatment-induced apoptosis in normal structures: 99mTc-HYNIC-rh-annexin V SPECT and CT image fusion. Eur J Nucl Med Mol Imaging. 2006;33(8):893–899
  6. Lampl Y, Lorberboym M, Blanckenberg F, Sadeh M, Gilad R. Annexin V SPECT imaging phosphatidylserine expression in patients with dementia. Neurology. 2006;66:1253–1254
  7. Kartachova M, Van Zandwijk N, Burger S, Van Tinteren H, Verheij M, Valdes Olmos R. Prognostic significance of 99mTc HYNIC-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. J Clin Oncol. 2007;25(18):2534–2539
  8. Kietselaer B, Reuteligsperger C, Boersma H, Heidendal G, Liem I, Crijns H, et al. Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure. J Nucl Med. 2007;48(4):562–567
  9. Van den Brande J, Koehler T, Zelinkova Z, Bennink R, Velde A, Cate F, et al. Prediction of antitumor necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease. Gut. 2007;56(4):509–517
  10. Zhu L, Liu B, Guo Y. Tc-99m direct labeling of annexin V for potential apoptosis imaging in vivo [abstract]. J Label Compd Radiopharm. 2003;46(Suppl 1):S324
  11. Blankenberg F, Katsikis P, Tait J, Davis R, Naumovski L, Ohtsuki K, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci. 1998;95:6349–6354
  12. Hofstra L, Liem I, Dumont E, Boersma H, Van Heerde W, Doevendans P, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet. 2000;256:209–212
  13. Kasina S, Rao T, Srinivasan A, Sanderson J, Fitzner J, Reno J, et al. Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent. J Nucl Med. 1991;32:1445–1451
  14. Yang D, Azhdarinia A, Wu P. In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V. Cancer Biother Radiopharm. 2001;16:73–83
  15. Subbarayan M, Hafeli U, Feyes D, Unnithan J, Emancipator S, Mukhtar H. A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy. J Nucl Med. 2003;44:650–656
  16. Vanderheyden JL, Liu G, He J, Patel B, Tait J, Hnatowitch D. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice. Nucl Med Biol. 2006;33:135–144
  17. Mc Quade P, Jones L, Welch M. 94mTc and 64Cu labeled annexin V positron emitting radiopharmaceuticals to study apoptosis [abstract]. J Label Compd Radiopharm. 2003;46(Suppl 1):S335
  18. Han E, Wong K, Park L, Yu S, Vanderheyden JL, Carrasquillo J, et al. Labeling annexin V with 99mTc-tricarbonyl PADA improved its organ clearance property [abstract]. J Nucl Med. 2002;43(5):374P
  19. Chang S, Lai P, Cheng H, Lo J. 99mTc (+I) tricarbonyl labeled hynic-annexin V as a potential apoptosis imaging agent [abstract]. J Nucl Med. 2003;44(5):316P
  20. Russel J, O'Donoghue J, Finn R, Koziorowski J, Ruan S, Humm J, et al. Iodination of annexin V for imaging apoptosis. J Nucl Med. 2002;43:671–677
  21. Zijlstra S, Gunawan J, Burchert W. Synthesis and evaluation of a 18F-labelled recombinant annexin V derivative, for identification and quantification of apoptotic cells with PET. Appl Radiat Isotopes. 2003;58:201–207
  22. Li C, Wen W, Wu Q. `Apoptosis induced by drug treatment correlates with uptake of 111In labelled pegylated annexin V in MDA-MB468 tumors. J Nucl Med. 2002;43:41
  23. Ito M, Tomiyoshi K, Takahashi N. Development of a new ligand, 11C-labeled annexin V, for PET imaging of apoptosis [abstract]. J Nucl Med. 2002;43(5):362P
  24. Smith-Jones P, Affroze A, Zanzonico P, Tait J, Larson S, Strauss W. 68Ga Labelling of annexin V: comparison to 99mTc-annexin V and 67Ga annexin [abstract]. J Nucl Med. 2003;44(5):49P–50P
  25. Tait J, Brown D, Gibson D, Blankenberg F, Strauss W. Development and characterization of annexin V mutants with endogenous chelation sites for 99mTc. Bioconjug Chem. 2000;11:918–925
  26. Tait J, Smith C, Gibson D. Development of annexin V mutants suitable for labeling with Tc(I)-carbonyl complex. Bioconjug Chem. 2002;13:1119–1123
  27. Mukherjee A, Kothari K, Toth G, Szemenzei E, Sarma H, Környei J, et al. 99mTc-Labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death. Nucl Med Biol. 2006;33:635–643
  28. Dollé F, Hinnen F, Lagnel B, Boisgard R, Sanson A, Russo-Marie F, et al. Radiosynthesis of a [18F]fluoropyridine-based maleimide reagent for protein labelling [abstract]. J Label Compd Radiopharm. 2003;46:S15
  29. Boisgard R, Blondel A, Dollé F. A new 18F and 99mTc radiopeptides for apoptosis imaging in tumor bearing mice [abstract]. J Nucl Med. 2003;44(5):49P
  30. Blankenberg F, Katsikis P, Tait J, Davis R, Naumovski L, Ohtsuki K, et al. Imaging of apoptosis (programmed cell death) with 99mTc annexin V. J Nucl Med. 1999;40:184–191
  31. Liu S, Edwards S, Harris A. A novel ternary ligand system for 99mTc-labelling of hydrazinonicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands. Bioconjug Chem. 1998;9:583–595
  32. Edwards S, Liu S, Barrett J, Harris A, Looby R, Ziegler M. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine coligands in labeling hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa antagonist with 99mTc. Biochem Chem. 1997;8:146–154
  33. Ono M, Arano Y, Mukai T, Kujioka Y, Ogawa K, Uehara T, et al. 99mTc-HYNIC-derivatized ternary ligand complexes for 99mTc-labeled polypeptides with low in vivo protein binding. Nucl Med Biol. 2001;28:215–224
  34. Su Z, He J, Rusckowski M, Hnatowitch D. In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands. Nucl Med Biol. 2003;30:141–149
  35. Rhodes B. Direct labeling of proteins with 99mTc. Nucl Med Biol. 1991;18(7):667–676
  36. Liu S, Edwards S, Looby R, Harris A, Poirier M, Barrett J, et al. Labeling a hydrazinonicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands. Bioconjugate Chem. 1996;7:63–71
  37. Liu S, Wescott C, Sato A, Wang Y, Liu N, Zhang Y, et al. Nitriles form mixed-coligand complexes with 99mTc-HYNIC-peptide. Nucl Med Biol. 2001;29:107–113
  38. Garron JY, Pasqualini R. Radiomarquage des macromolécules par le technétium-99m - voie indirecte. In:  Comet M,  Vidal M editor. Radiopharmaceutiques. Grenoble: Presses Universitaires de Grenoble; 1998;p. 379–395
  39. Banerjee S, Maresca K, Francesconi L, Valliant J, Babich J, Zubieta J. New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and strategy for new chelate design. Nucl Med Biol. 2005;32:1–20
  40. Ultee M, Bridger G, Abrams M, Longley C, Burton C, Larsen S, et al. Tumor imaging with technetium 99m-labeled hydrazinonicotinamide-Fab' conjugates. J Nucl Med. 1997;38:133–138
  41. Steffen M, Oosterwijk E, Kranenborg M, Manders J, Debruyne F, Corstens F, et al. In vivo and in vitro characterization of three 99mTc-labeled monoclonal antibody G250 preparation. J Nucl Med. 1999;40:829–836
  42. Ono M, Arano Y, Mukai T, Fujioka Y, Ogawa K, Namba S, et al. Plasma protein binding of 99mTc-labeled hydrazino nicotinamide derivatized polypeptides and peptides. Nucl Med Biol. 2001;28:155–164
  43. Ruckowski M, Qu T, Gupta S, Ley A, Hnatowich D. A comparison in monkeys of 99mTc labeled to a peptide by 4 methods. J Nucl Med. 2001;42:1870–1877
  44. Tait J, Smith C, Levashova Z, Bhavesh P, Blanckenberg F, Vanderheyden JL. Improved detection of cell death in vivo with annexin V radiolabeled by site-specific method. J Nucl Med. 2006;47(9):1546–1553
  45. Ono M, Arano Y, Uehara T, Fujioka Y, Ogawa K, Namba S, et al. Intracellular metabolic fate of radioactivity after injection of technetium 99m-labeled hydrazino nicotinamide derivatized proteins. Bioconjug Chem. 1999;10:386–394
  46. Biechlin ML, du Moulinet d'Hardemare A, Fraysse M, Gilly FN, Bonmartin A. Improvement of radiolabelling proteins with the 99mTc-tricarbonyl-core [99mTc(CO)3]+, by thiol-derivatization with iminothiolane: application to γ-globulins and annexin V. J Label Compd Radiopharm. 2005;48:873–885
  47. Egli A, Alberto R, Tannahill L, Schilbi R, Abram U, Schaffland A, et al. Organometallic 99mTc-aquaion labels peptide to an unprecedented high specific activity. J Nucl Med. 1999;40:1913–1917
  48. Abrams M, Juweid M, Tenkate C, Schwarte D, Hauser M, Gaul F, et al. Technetium-99m-human polyclonal IgG radiolabeled via hydrazinonicotinamide derivative for imaging focal sites of injection in rats. J Nucl Med. 1990;31:2022–2027
  49. McCall M, Diril H, Meares C. Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane. Bioconjug Chem. 1990;1:222–226
  50. Amarthey J, Parhar R, Al-Jammaz I. Synthesis and preliminary evaluation of Tc-99m-labeled somatostatin analog (RC-160) using «3 + 1» mixed ligand approach. Nucl Med Biol. 2000;28:225–233
  51. King T, Zhao S, Lam T. Preparation of protein conjugates via intermolecular hydrazone linkage. Biochemistry. 1986;25:5574–5579
  52. Garron JY, Pasqualini R, Saccavini JC. Radiomarquage des anticorps monoclonaux et des peptides par le technétium 99m – voie directe. In:  Comet M,  Vidal M editor. Radiopharmaceutiques. Grenoble: Presses Universitaires de Grenoble; 1998;p. 365–378
  53. Delmon-Moingeon L, Moretti JL, Mahmood A, Jones AG. Stratégies de marquage d'anticorps monoclonaux et molécules apparentées par le technétium-99m. J Med Nucl Biophys. 1991;4:401–409
  54. Tait J, Gibson D, Smith C. Measurement of the affinity and cooperativity of annexin V-membrane binding under conditions of low membrane occupancy. Anal Biochem. 2004;329:112–119
  55. Wood B, Gibson D, Tait J. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical association. Blood. 1996;88(5):1873–1880
  56. Funakoshi T, Hendrickson L, McMullen B, Fujikawa K. Primary structure of human placental anticoagulant protein. Biochemistry. 1987;26:8087–8092
  57. Aebischer N, Sidorenkova E, Ravera M, Laurenczy G, Osella D, Weber J, et al. Trans- and cis-water reactivities in d6 octahedral ruthenium(+II) pentaaqua complexes: experimental and density functional theory studies. Inorganic Chem. 1997;36:6009–6020
  58. Alberto R, Schibli R, Abram U, Egli A, Knapp F, Schubiger P. Potential of the “[M(CO)3]+” (M=Re, Tc) moiety for the labeling of biomolecules. Radiochim Acta. 1997;79:99–103
  59. Waibel R, Alberto R, Willuda J, Finnern R, Schilbi R, Stichelberger A, et al. Stable one-step technetium 99m labeling of His-tagged recombinant proteins with a novel Tc(+I)-carbonyl complex. Nat Biotechnol. 1999;17:897–901
  60. Lazarova N, Babich J, Valliant J, Schaffer P, James S, Zubieta J. Thiol- and thioether-based bifunctional chelates for the {M(CO)3}+ core (M=Tc, Re). Inorg Chem. 2005;44:6763–6770
  61. Jocelyn P. Spectrophotometric assay of thiols. Methods Enzymol. 1987;143:44–67
  62. Alberto R, Schibli R, Schubiger P, Abram U, Kaden T. Reactions with the technetium and rhenium carbonyl complexes (NEt4)[MX3(CO)3]. Synthesis and structure of Tc(CN-But)3(CO)3](NO3) and (NEt4)[Tc2(μ-SCH2CH2OH)3(CO)3]. Polyhedron. 1996;15:1079–1089
  63. Kramer D, Davison A, Davis W, Jones A. N-(2-Mercaptoethyl)picolylamine as a diaminomonothiolate ligand for the “fac-[Re(CO)3]+” core. Inorg Chem. 2002;41:6181–6183
  64. Schilbi R, La Bella R, Alberto R, Garcia-Garayoa E, Ortner K, Abram U, et al. Influence of the density of ligand systems on the in vitro and in vivo behavior of 99mTc-tricarbonyl complexes: a hint for the future functionalization of biomolecules. Bioconjug Chem. 2000;11:345–351
  65. Mundwiller S, Kündig M, Ortner K, Alberto R. A new [2+1] mixed ligand concept based on [99(m)Tc(OH2)3(CO)3]+: a basic study. Dalton Trans. 2004;1320–1328

PII: S0969-8051(08)00117-0

doi: 10.1016/j.nucmedbio.2008.05.009

Nuclear Medicine and Biology
Volume 35, Issue 6 , Pages 679-687 , August 2008

Article Tools

* Image Usage & Resolution